Scopus Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Scopus Biopharma

18/05/2021 24:01

* Scopus Biopharma Inc  SCPS.OQ  reported a quarterly adjusted
loss of 22 cents​​ per share for the quarter ended in March. The
lone analyst forecast for the quarter was for a loss of 8 cents
per share.
* Reported revenue was zero​;  analysts expected zero. 
* Scopus Biopharma Inc's reported EPS for the quarter was a loss
of 22 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Scopus Biopharma Inc shares had fallen by 29.7% this
quarter and lost 60.0% so far this year.
* The company reported a quarterly loss of $3.41 million.
* Wall Street's median 12-month price target for Scopus
Biopharma Inc is $20.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 17 at 11:01 p.m. GMT.
​All figures in US dollars